Cargando…

Aggressiveness of care at end of life in patients with high‐grade glioma

BACKGROUND: Patients with high‐grade glioma (HGG) face unique challenges toward the end of life (EoL), given their aggressive trajectory and neurologic deterioration. Aggressiveness of medical care at EoL has been identified as an important quality metric for oncology patients. At this time, limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrison, Rebecca A., Ou, Alexander, Naqvi, Syed M. A. A., Naqvi, Syed M., Weathers, Shiao‐Pei S., O'Brien, Barbara J., de Groot, John F., Bruera, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633215/ https://www.ncbi.nlm.nih.gov/pubmed/34755486 http://dx.doi.org/10.1002/cam4.4344

Ejemplares similares

BCR-NTRK2 fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behavior
por: Jones, Karra A., et al.
Publicado: (2019)

Pre-surgical connectome features predict IDH status in diffuse gliomas
por: Kesler, Shelli R., et al.
Publicado: (2019)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

End‐of‐Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs
por: Dalal, Shalini, et al.
Publicado: (2017)

Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma
por: Lin, Han, et al.
Publicado: (2021)

Aggressiveness of Grade 4 Gliomas of Adults
por: Deacu, Mariana, et al.
Publicado: (2022)

COVD-30. A SNAPSHOT OF THE IMPACT OF COVID-19 ON PATIENTS WITH NERVOUS SYSTEM TUMORS
por: Aaroe, Ashley, et al.
Publicado: (2020)

An autophagic gene‐based signature to predict the survival of patients with low‐grade gliomas
por: Chen, Jian, et al.
Publicado: (2021)

The transcriptomic profile of ovarian cancer grading
por: Yao, Cindy Q, et al.
Publicado: (2015)

Present status and upcoming prospects of hedgehog pathway inhibitors in small cell lung cancer therapy
por: Naqvi, Syed Hassan Abbas, et al.
Publicado: (2013)

Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV
por: McDuff, Susan G. R., et al.
Publicado: (2019)

Genetic and expression variations of cell cycle pathway genes in brain tumor patients
por: Naqvi, Anum Zehra, et al.
Publicado: (2020)

A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma
por: de Groot, John, et al.
Publicado: (2022)

A germline PALB2 pathogenic variant identified in a pediatric high-grade glioma
por: Zhong, Yiming, et al.
Publicado: (2020)

Yoga Program for High-Grade Glioma Patients Undergoing Radiotherapy and Their Family Caregivers
por: Milbury, Kathrin, et al.
Publicado: (2017)

Trametinib therapy for children with neurofibromatosis type 1 and life‐threatening plexiform neurofibroma or treatment‐refractory low‐grade glioma
por: Ronsley, Rebecca, et al.
Publicado: (2021)

Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study
por: Zhang, Yiwen, et al.
Publicado: (2022)

On high‐risk, low‐grade glioma: What distinguishes high from low?
por: Geurts, Marjolein, et al.
Publicado: (2018)

Differences in the preferential location and invasiveness of diffuse low‐grade gliomas and their impact on outcome
por: Latini, Francesco, et al.
Publicado: (2020)

Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma
por: Robinson, M Hope, et al.
Publicado: (2020)

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma
por: Hölzl, Dorothee, et al.
Publicado: (2021)

Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma
por: Patil, Vijay M., et al.
Publicado: (2020)

Potential neurologic and oncologic implications of the novel coronavirus
por: Aaroe, Ashley Elimar, et al.
Publicado: (2020)

Etiology and severity of various forms of ocular war injuries in patients presenting at an Army Hospital in Pakistan
por: Naqvi, Syed Abid Hassan
Publicado: (2017)

Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma
por: Aragon-Sanabria, Virginia, et al.
Publicado: (2022)

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
por: Watts, Eleanor L, et al.
Publicado: (2022)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020)

Effects of the MAML2 genetic variants in glioma susceptibility and prognosis
por: Zhang, Ming, et al.
Publicado: (2019)

Physician migration at its roots: a study on the factors contributing towards a career choice abroad among students at a medical school in Pakistan
por: Sheikh, Asfandyar, et al.
Publicado: (2012)

Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Compassion is a key quality for palliative care teams
por: Kang, Jung Hun, et al.
Publicado: (2018)

Advances in treating glioblastoma
por: Weathers, Shiao-Pei, et al.
Publicado: (2014)

A Paraurethral Aggressive (Deep) Angiomyxoma
por: York, Daniel, et al.
Publicado: (2022)

Phase II evaluation of sunitinib in the treatment of recurrent or refractory high‐grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021
por: Wetmore, Cynthia, et al.
Publicado: (2016)

FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma
por: Madan, Evanka, et al.
Publicado: (2016)

Comment on “Expression of CD44 and the survival in glioma: a meta-analysis”
por: Hou, Chongxian, et al.
Publicado: (2020)

A research protocol for a pilot, randomized controlled trial designed to examine the feasibility of a dyadic versus individual yoga program for family caregivers of glioma patients undergoing radiotherapy
por: Milbury, Kathrin, et al.
Publicado: (2019)

Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients
por: Chen, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mjtb39o1mjnb3f0bnrm8frcdnt